시장보고서

상품코드

1498731

세계의 어류 백신 시장 : 백신 유형별, 적응증별, 투여 경로별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 예측(2024-2032년)

Fish Vaccines Market, By Vaccine Type, By Indication, By Route of Administration, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: 2024년 06월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 316 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

어류 백신 시장 규모는 2023년에 3억 8,240만 달러로 2024-2032년에 걸쳐 CAGR 7.40%로 확대

어류 백신 시장 - 시장 역학

양식 활동 증가는 어류 백신 시장의 성장을 가속

양식 활동의 급증은 어류 백신 시장의 성장을 크게 촉진하고 있습니다. 유엔 식량농업기관(FAO)에 따르면 세계 양식 생산량은 꾸준히 증가하고 있으며, 2030년에는 1억 900만 톤에 달할 것으로 예측되고 있습니다. 이 확대에는 단백질원으로서의 물고기에 대한 수요 증가가 박차를 가하고 있어 지속가능한 수율을 확보하기 위해 효과적인 건강관리가 필요합니다. 예를 들면, 연어 양식의 선진국인 노르웨이에서는 전염성 연어 빈혈이나 어류 오르토레오 바이러스 등의 질병과 싸우기 위해 어류 백신이 대폭 채용되어 생산 효율이 향상되고 있습니다. 이러한 동향은 물고기의 건강을 유지하고 수산 양식 산업의 번영을 지원하는 백신의 중요한 역할을 부각하고 있습니다.

어류 백신 시장 - 주요 인사이트

당사의 리서치 애널리스트가 공유한 분석에 따르면 세계 시장은 예측 기간(2024-2032년)에 약 7.40%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예측되고 있습니다.

백신의 유형별 세분화에 따르면, 2023년에는 약독 백신이 가장 큰 시장 점유율을 보여줄 것으로 예상됩니다.

적응증별로는 2023년에 세개종증이 주요한 유형이 되고 있습니다.

투여 경로별로 경구는 2023년의 주요 유형이었습니다.

지역별로는 2023년 유럽이 주요 수익원이 되었습니다.

어류 백신 시장 - 세분화 분석 :

생선 백신 세계 시장은 백신 유형, 적응증, 투여 경로, 최종 사용자 및 지역에 따라 세분화됩니다.

시장은 백신 유형에 따라 7가지 범주로 나뉩니다: 사균 백신, 불활성화 백신, 약독화 백신, 톡소이드 백신, 아단위 백신, 결합 백신, 재조합 벡터 백신. 어류 백신 시장을 선도하는 것은 강력하고 장기간 지속되는 면역 반응을 유도하는 효과가 있는 불활성화 백신입니다. 불활성화 백신은 안전과 안정성을 제공합니다. 멸균 백신, 아단위 백신, 톡소이드 백신은 특정 요구에 부응하며, 결합 백신 및 재조합 벡터 백신은 첨단 면역화 기술을 가진 신흥 부문입니다.

시장은 적응증별로 4가지 범주로 분류된다: 세종종증, 비브리오증, 엘시니아증, 장관패혈증입니다. 세종종증은 널리 만연하고 연어과 어류에 큰 영향을 미치기 때문에 생선 백신 시장을 독점하고 있습니다. 비브리오증이 이에 이어 세계적으로 다양한 어종에 영향을 미치고 있습니다. 엘시니아증과 장성 패혈증도 양식에서 특정 박테리아 감염을 대상으로 상당한 시장 점유율을 차지합니다.

어류 백신 시장 - 지리적 통찰

유럽, 특히 노르웨이와 스코틀랜드와 같은 국가들은 고급 수산 양식 산업과 어류 예방 접종의 높은 채용률로 시장을 선도하고 있습니다. 북미, 특히 미국과 캐나다는 또한 대규모 연어와 송어 양식으로 큰 시장 성장을 보여줍니다. 아시아태평양에서는 중국, 인도, 베트남 등의 국가들이 양식 생산 증가와 물고기 건강 관리에 대한 의식 증가로 급속한 시장 확대를 경험하고 있습니다. 라틴아메리카와 중동 및 아프리카는 신흥 시장이며 양식 인프라에 대한 투자 확대와 지속 가능한 양식 방법을 추진하는 정부의 이니셔티브에 의해 지원되고 있습니다.

어류 백신 시장 - 경쟁 구도 :

Zoetis Inc., Merck & Co., Inc.(자회사의 MSD Animal Health를 통해), Elanco Animal Health, HIPRA 등의 대기업은 다양한 생선 질병을 대상으로 한 백신의 다양한 포트폴리오를 제공함으로써, 시장을 독점하고 있습니다. 이러한 기업들은 보다 효과적인 새로운 백신 도입, 백신 전달 방법 개선, 전략적 제휴 및 인수를 통한 지리적 범위 확대 등 연구개발에 주력하고 있습니다. 예를 들어, Zoetis에 의한 Fish Vet Group의 인수는 진단 능력과 백신 제공을 강화함으로써 시장에서의 입지를 강화했습니다. 또한 백신 기술을 진보시켜 새로운 어병에 대한 대처를 목표로 하는 기업과 학술기관의 제휴도 활발합니다. 예를 들어, 2023년 3월, Indian Immunologicals(IIL)는 민물고기 출혈성 패혈증에 대한 백신의 상업적 개발을 위해 Central Institute of Freshwater Aquaculture(CIFA)와 제휴했습니다. 또한, 지역의 중소기업도 지역의 특정 요구와 규제 요건을 충족함으로써 시장에 기여하고 있습니다.

소개
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제12장 주요 벤더 분석-어류 백신 업계

경쟁 대시보드
기업 프로파일
- Aleph Farms
- BioMar Group
- Ceva Sante Animale
- Elanco Animal Health(Eli Lilly and Company의 일부)
- Fish Vet Group(Benchmark Holdings plc의 일부)
- HIPRA
- Hipra Animal Health Limited
- Intervet Inc.(Merck &Co., Inc.의 일부)
- Merck Animal Health(Merck &Co., Inc.의 일부)
- MSD Animal Health(Merck &Co., Inc.의 일부)
- Nisseiken Co., Ltd.
- Syndel Laboratories
- Vaxxinova
- Vetech Laboratories
- Vetoquinol SA
- Zoetis Inc.
- 기타

제13장 애널리스트의 전방위 전망

JHS 24.06.28

REPORT HIGHLIGHT

Fish Vaccines Market size was valued at USD 382.40 million in 2023, expanding at a CAGR of 7.40% from 2024 to 2032.

The Fish Vaccines Market involves the development and distribution of vaccines aimed at preventing diseases in fish populations, crucial for aquaculture health management. The increasing demand for fish protein, rising aquaculture practices, and advancements in vaccine technologies are growth factors in the market. Additionally, growing awareness about sustainable aquaculture and the need to reduce antibiotic usage in fish farming further bolsters the market. However, challenges such as high vaccine development costs, regulatory hurdles, and limited access to vaccines in developing regions restrain growth. Opportunities lie in the expansion of aquaculture in emerging markets, innovation in vaccine delivery methods, and government initiatives promoting sustainable fish farming practices.

Fish Vaccines Market- Market Dynamics

Rising Aquaculture Activities Propel Growth in the Fish Vaccines Market

The surge in aquaculture activities is significantly driving the growth of the Fish Vaccines Market. According to the Food and Agriculture Organization (FAO), global aquaculture production has been steadily increasing and is projected to reach 109 million tonnes in 2030. This expansion is fueled by the growing demand for fish as a protein source, necessitating effective health management practices to ensure sustainable yields. For instance, Norway, a leading country in salmon farming, has seen substantial adoption of fish vaccines to combat diseases like infectious salmon anemia and piscine orthoreovirus, enhancing production efficiency. Such trends highlight the crucial role of vaccines in maintaining fish health and supporting the thriving aquaculture industry.

Fish Vaccines Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.40% over the forecast period (2024-2032)

Based on Vaccine Type segmentation, Attenuated Vaccine was predicted to show maximum market share in the year 2023

Based on Indication segmentation, Furunculosis was the leading type in 2023

Based on Route of Administration segmentation, Oral was the leading type in 2023

On the basis of region, Europe was the leading revenue generator in 2023

Fish Vaccines Market- Segmentation Analysis:

The Global Fish Vaccines Market is segmented on the basis of Vaccine Type, Indication, Route of Administration, End-User, and Region.

The market is divided into seven categories based on Vaccine Type: Killed Vaccine, Inactivated Vaccine, Attenuated Vaccine, Toxoid Vaccine, Subunit Vaccine, Conjugate Vaccine, and Recombinant Vector Vaccines. Attenuated vaccines lead the Fish Vaccines Market due to their effectiveness in inducing strong and long-lasting immune responses. Inactivated vaccines follow, offering safety and stability. Killed vaccines, subunit vaccines, and toxoid vaccines cater to specific needs, while conjugate and recombinant vector vaccines represent emerging segments with advanced immunization techniques.

The market is divided into four categories based on Indication: Furunculosis, Vibriosis, Yersiniosis, and Enteric septicaemia. Furunculosis dominates the Fish Vaccines Market due to its widespread prevalence and significant impact on salmonids. Vibriosis follows, affecting various fish species globally. Yersiniosis and enteric septicaemia also hold substantial market shares, targeting specific bacterial infections in aquaculture.

Fish Vaccines Market- Geographical Insights

Europe leads the market, particularly countries like Norway and Scotland, due to their advanced aquaculture industries and high adoption of fish vaccination practices. North America, notably the United States and Canada, also shows significant market growth driven by extensive salmon and trout farming. In the Asia-Pacific region, countries such as China, India, and Vietnam are experiencing rapid market expansion due to increasing aquaculture production and rising awareness about fish health management. Latin America and the Middle East & Africa are emerging markets, supported by growing investments in aquaculture infrastructure and government initiatives promoting sustainable fish farming practices.

Fish Vaccines Market- Competitive Landscape:

Leading companies such as Zoetis Inc., Merck & Co., Inc. (through its subsidiary MSD Animal Health), Elanco Animal Health, and HIPRA dominate the market by offering a diverse portfolio of vaccines targeting various fish diseases. These companies focus on research and development to introduce new and more effective vaccines, improve vaccine delivery methods, and expand their geographical reach through strategic partnerships and acquisitions. For instance, Zoetis's acquisition of Fish Vet Group has strengthened its position in the market by enhancing its diagnostic capabilities and vaccine offerings. Additionally, collaboration between companies and academic institutions is prevalent, aiming to advance vaccine technology and address emerging fish diseases. For instance, in March 2023, Indian Immunologicals (IIL) partnered with the Central Institute of Freshwater Aquaculture (CIFA) for the commercial development of a vaccine against hemorrhagic septicemia in freshwater fish. Furthermore, smaller, regional players also contribute to the market by catering to specific local needs and regulatory requirements.

Recent Developments:

In November 2022, Indian Immunologicals (IIL) planned to launch a fish vaccine, marking its entry into the aquaculture market. The vaccine will be developed in partnership with the Central Institute of Fisheries Education (CIFE) for bacterial diseases in freshwater fish, such as Columnaris Disease and Edwardsiellosis.

In May 2024, HIPRA, announced the launch of ICTHIOVAC VNN, an inactivated vaccine against Viral Nervous Necrosis (VNN) in sea bass, in the Mediterranean region. This vaccine is designed to protect sea bass against VNN, a significant disease affecting the aquaculture industry in the region

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FISH VACCINES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Aleph Farms

BioMar Group

Ceva Sante Animale

Elanco Animal Health (part of Eli Lilly and Company)

Fish Vet Group (part of Benchmark Holdings plc)

HIPRA

Hipra Animal Health Limited

Intervet Inc. (part of Merck & Co., Inc.)

Merck Animal Health (part of Merck & Co., Inc.)

MSD Animal Health (part of Merck & Co., Inc.)

Nisseiken Co., Ltd.

Syndel Laboratories

Vaxxinova

Vetech Laboratories

Vetoquinol S.A.

Zoetis Inc.

Others

GLOBAL FISH VACCINES MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019 - 2032

Killed Vaccine
Inactivated Vaccine
Attenuated Vaccine
Toxoid Vaccine
Subunit Vaccine
Conjugate Vaccine
Recombinant Vector Vaccines

GLOBAL FISH VACCINES MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

Furunculosis
Vibriosis
Yersiniosis
Enteric septicaemia
Others

GLOBAL FISH VACCINES MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

Injection
Immersion
Spray
Oral

GLOBAL FISH VACCINES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Aquaculture Farms
Hatcheries
Research Institutes

GLOBAL FISH VACCINES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Fish Vaccines Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Fish Vaccines Market Snippet by Vaccine Type
- 2.1.2. Fish Vaccines Market Snippet by Indication
- 2.1.3. Fish Vaccines Market Snippet by Route of Administration
- 2.1.4. Fish Vaccines Market Snippet by End-User
- 2.1.5. Fish Vaccines Market Snippet by Country
- 2.1.6. Fish Vaccines Market Snippet by Region
2.2. Competitive Insights

3. Fish Vaccines Key Market Trends

3.1. Fish Vaccines Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Fish Vaccines Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Fish Vaccines Market Opportunities
3.4. Fish Vaccines Market Future Trends

4. Fish Vaccines Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Fish Vaccines Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Fish Vaccines Market Landscape

6.1. Fish Vaccines Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Fish Vaccines Market - By Vaccine Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Vaccine Type, 2023 & 2032 (%)
- 7.1.2. Killed Vaccine
- 7.1.3. Inactivated Vaccine
- 7.1.4. Attenuated Vaccine
- 7.1.5. Toxoid Vaccine
- 7.1.6. Subunit Vaccine
- 7.1.7. Conjugate Vaccine
- 7.1.8. Recombinant Vector Vaccines

8. Fish Vaccines Market - By Indication

8.1. Overview
- 8.1.1. Segment Share Analysis, By Indication, 2023 & 2032 (%)
- 8.1.2. Furunculosis
- 8.1.3. Vibriosis
- 8.1.4. Yersiniosis
- 8.1.5. Enteric septicaemia
- 8.1.6. Others

9. Fish Vaccines Market - By Route of Administration

9.1. Overview
- 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
- 9.1.2. Injection
- 9.1.3. Immersion
- 9.1.4. Spray
- 9.1.5. Oral

10. Fish Vaccines Market - By End-User

10.1. Overview
- 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 10.1.2. Aquaculture Farms
- 10.1.3. Hatcheries
- 10.1.4. Research Institutes

11. Fish Vaccines Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Fish Vaccines Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Fish Vaccines Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Fish Vaccines Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Fish Vaccines Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Fish Vaccines Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Fish Vaccines Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. Aleph Farms
- 12.2.2. BioMar Group
- 12.2.3. Ceva Sante Animale
- 12.2.4. Elanco Animal Health (part of Eli Lilly and Company)
- 12.2.5. Fish Vet Group (part of Benchmark Holdings plc)
- 12.2.6. HIPRA
- 12.2.7. Hipra Animal Health Limited
- 12.2.8. Intervet Inc. (part of Merck & Co., Inc.)
- 12.2.9. Merck Animal Health (part of Merck & Co., Inc.)
- 12.2.10. MSD Animal Health (part of Merck & Co., Inc.)
- 12.2.11. Nisseiken Co., Ltd.
- 12.2.12. Syndel Laboratories
- 12.2.13. Vaxxinova
- 12.2.14. Vetech Laboratories
- 12.2.15. Vetoquinol S.A.
- 12.2.16. Zoetis Inc.
- 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us